Loading…
Lobbying Spend
—
Filings
20
Firms Hired
1
Active Period
2022–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Dr. Michael C. Burgess Preventive Health Savings Act
2024 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.766/S.114 Preventive Health Savings Act Pandemic preparedness, life science innovation and competitiveness, preemptive health and medicine, biomanufacturing, next generation vaccines and therapeutics, PAPHA reauthorization, AI policy and regulation, AMR research, rare disease PRV, ag-biotech policy and regulation
Client expense: — · Firm income: $80,000
Matched citations: H.R.766
Preventive Health Savings Act
2024 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.766/S.114 Preventive Health Savings Act Pandemic preparedness, life science innovation and competitiveness, preemptive health and medicine, biomanufacturing, next generation vaccines and therapeutics, PAPHA reauthorization, AI policy and regulation, AMR research, rare disease PRV, ag-biotech policy and regulation
Client expense: — · Firm income: $80,000
Matched citations: S.114
Dr. Michael C. Burgess Preventive Health Savings Act
2024 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.766/S.114 Preventive Health Savings Act Pandemic preparedness, life science innovation and competitiveness, preemptive health and medicine, biomanufacturing, next generation vaccines and therapeutics, PAPHA reauthorization, AI policy and regulation, AMR research
Client expense: — · Firm income: $80,000
Matched citations: H.R.766
Preventive Health Savings Act
2024 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.766/S.114 Preventive Health Savings Act Pandemic preparedness, life science innovation and competitiveness, preemptive health and medicine, biomanufacturing, next generation vaccines and therapeutics, PAPHA reauthorization, AI policy and regulation, AMR research
Client expense: — · Firm income: $80,000
Matched citations: S.114
Dr. Michael C. Burgess Preventive Health Savings Act
2024 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.766/S.114 Preventive Health Savings Act Pandemic preparedness, life science innovation and competitiveness, preemptive health and medicine, biomanufacturing, next generation vaccines and therapeutics, PAPHA reauthorization, AI policy and regulation, AMR research
Client expense: — · Firm income: $80,000
Matched citations: H.R.766
Preventive Health Savings Act
2024 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.766/S.114 Preventive Health Savings Act Pandemic preparedness, life science innovation and competitiveness, preemptive health and medicine, biomanufacturing, next generation vaccines and therapeutics, PAPHA reauthorization, AI policy and regulation, AMR research
Client expense: — · Firm income: $80,000
Matched citations: S.114
Source: Senate LDA